Boutilier, A. S. W., & Gardner, D. M. (2003). Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: An evidence-based pharmacotherapeutic case report. Journal of Clinical Pharmacy & Therapeutics, 28(1), 69. https://doi.org/10.1046/j.1365-2710.2003.00453.x
Chicago Style (17th ed.) CitationBoutilier, A. S. W., and D. M. Gardner. "Reassessing the Contraindication of Zolmitriptan and Serotonin Reuptake Inhibitors: An Evidence-based Pharmacotherapeutic Case Report." Journal of Clinical Pharmacy & Therapeutics 28, no. 1 (2003): 69. https://doi.org/10.1046/j.1365-2710.2003.00453.x.
MLA (9th ed.) CitationBoutilier, A. S. W., and D. M. Gardner. "Reassessing the Contraindication of Zolmitriptan and Serotonin Reuptake Inhibitors: An Evidence-based Pharmacotherapeutic Case Report." Journal of Clinical Pharmacy & Therapeutics, vol. 28, no. 1, 2003, p. 69, https://doi.org/10.1046/j.1365-2710.2003.00453.x.